Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Vascular Surgery

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jvs.2009.07.119PMID 19837545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A review of lipid management in primary and secondary prevention.

  2009cited by this paper
• Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.

  2009cited by this paper
• Pleiotropic effects of statins--clinical evidence.

  2009cited by this paper
• ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques.

  2009cited by this paper
• Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

  2009cited by this paper
• Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification

  2009cited by this paper
• Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).

  2009cited by this paper
• Statins for the prevention of first or recurrent stroke.

  2008cited by this paper
• Rapid Stabilization of Vulnerable Carotid Plaque Within 1 Month of Pitavastatin Treatment in Patients With Acute Coronary Syndrome

  2008cited by this paper
• The Role of Carotid Plaque Vulnerability and Inflammation in the Pathogenesis of Acute Ischemic Stroke

  2008cited by this paper
• Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients.

  2008cited by this paper
• The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.

  2008cited by this paper
• An Overview of the Extra-Lipid Effects of Rosuvastatin

  2008cited by this paper
• Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.

  2008cited by this paper
• Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome

  2008cited by this paper
• Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

  2008cited by this paper
• Quantitative Evaluation of Carotid Plaque Echogenicity by Integrated Backscatter Analysis: Correlation with Symptomatic History and Histologic Findings

  2008cited by this paper
• Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.

  2008cited by this paper
• A three-dimensional ultrasonographic quantitative analysis of non-ulcerated carotid plaque morphology in symptomatic and asymptomatic carotid stenosis.

  2008cited by this paper
• Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients.

  2008cited by this paper
• Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal–medial thickness in patients with coronary heart disease

  2007cited by this paper
• Imaging the Cellular Biology of the Carotid Plaque

  2007cited by this paper
• Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement*

  2007cited by this paper
• Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

  2007cited by this paper
• Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro.

  2007cited by this paper
• Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria

  2007cited by this paper
• Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia.

  2006cited by this paper
• Effect of Atorvastatin on Plasma Osteopontin Levels in Patients With Hypercholesterolemia

  2006cited by this paper
• The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease

  2006cited by this paper
• Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization

  2006cited by this paper
• Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

  2004cited by this paper
• Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis

  2004cited by this paper
• Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.

  2003cited by this paper
• Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference.

  2003cited by this paper
• Direct B-mode NASCET-style stenosis measurement and Doppler ultrasound as parameters for assessment of internal carotid artery stenosis.

  2002cited by this paper
• Variability in measurement of internal carotid artery stenosis by arch angiography and duplex ultrasonography--time for a reappraisal?

  2001cited by this paper
• NK‐104, a 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

  1998cited by this paper

• Histologically Verified Carotid Plaque Characteristics by Ultrasound: A Diagnostic Accuracy Systematic Review.

  2025cites this paper
• Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis

  2025cites this paper
• Rivaroxaban Does Not Alter Carotid Plaque Echolucency, Volume, or Neovascularisation.

  2025cites this paper
• Neural repair function of osteopontin in stroke and stroke‑related diseases (Review)

  2024cites this paper
• The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review

  2024cites this paper
• Echogenicity of atherosclerotic plaque - a criterion for assessing the dynamics and prognosis of cardiovascular diseases

  2024cites this paper
• Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review

  2024cites this paper
• CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis

  2024cites this paper
• Temporal Trends and Determinants of Stroke Risk in Patients With Medically Treated Asymptomatic Carotid Stenosis

  2023cites this paper
• Application potential of senolytics in clinical treatment

  2023cites this paper
• Qualitative and quantitative ultrasound parameters of carotid atherosclerotic plaques in patients with moderate cardiovascular risk according to the SCORE scale: 7-year prospective follow-up study

  2023cites this paper
• The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review

  2023cites this paper
• Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

  2022cites this paper
• Echolucent carotid plaques becomes more echogenic over time - a 3D ultrasound study.

  2022cites this paper
• A systematic review and meta-analyses on the effects of atorvastatin on blood pressure and heart rate.

  2022cites this paper
• Plasma proteins, cognitive decline, and 20‐year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies

  2021cites this paper
• Biomarkers in unstable carotid plaque: Physiopathology and Prediction.

  2021cites this paper
• Doppler Ultrasound Monitoring of Echogenicity in Asymptomatic Subcritical Carotid Stenosis and Assessment of Response to Oral Supplementation of Vitamin K2 (PLAK2 Randomized Controlled Trial)

  2021cites this paper
• Carotid Atherosclerosis, Ultrasound and Lipoproteins

  2021cites this paper
• How to Use Statins in Secondary Prevention of Atherosclerotic Diseases: from the Beneficial Early Initiation to the Potentially Unfavorable Discontinuation

  2021cites this paper
• Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification

  2020cites this paper
• Pharmacological interventions for asymptomatic carotid stenosis.

  2020cites this paper
• Association of plasma proteins with rate of cognitive decline and dementia: 20-year follow-upof the Whitehall II and ARIC cohort studies

  2020cites this paper
• Primary Cardiovascular Disease Prevention: Risk Factors Control vs. Imaging Subclinical Atherosclerosis

  2020cites this paper
• Evaluating the Efficacy of Atorvastatin on Patients with Carotid Plaque by an Innovative Ultrasonography.

  2019cites this paper
• Carotid Artery Echolucency, Texture Features, and Incident Cardiovascular Disease Events: The MESA Study

  2019cites this paper
• Changes in carotid artery structure with smoking cessation

  2019cites this paper
• Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis.

  2019cites this paper
• Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.

  2018cites this paper
• Detection of unstable carotid plaque in ischemic stroke prevention

  2018cites this paper
• Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease

  2018cites this paper
• Improved plaque neovascularization following 2-year atorvastatin therapy based on contrast-enhanced ultrasonography: A pilot study.

  2018cites this paper
• Early Carotid Endarterectomy Provides a Better Neurological Outcome in Symptomatic Patients: A Single-Center Experience.

  2017cites this paper
• Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment

  2017cites this paper
• Pretreatment with and ongoing use of omega‐3 fatty acid ethyl esters reduce the slow‐flow phenomenon and prevent in‐stent restenosis in patients undergoing carotid artery stenting

  2017cites this paper
• Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.

  2016cites this paper
• Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinic

  2016cites this paper
• Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.

  2016cites this paper
• Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis.

  2016cites this paper
• Evaluación cardiovascular sistemática de pacientes incidentes con gota

  2016cites this paper
• Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

  2015cites this paper
• Rosuvastatin‐Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study

  2015cites this paper
• Galectin-3, Carotid Plaque Vulnerability, and Potential Effects of Statin Therapy.

  2015cites this paper
• Impact of statins on serial coronary calcification during atheroma progression and regression.

  2015cites this paper
• Ultrasound Assessment of Carotid Plaque Echogenicity Response to Statin Therapy: A Systematic Review and Meta-Analysis

  2015influential citation
• Atherosclerosis and general principles of arterial imaging.

  2015cites this paper
• Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.

  2015cites this paper
• Distribution of Alkaline Phosphatase, Osteopontin, RANK Ligand and Osteoprotegerin in Calcified Human Carotid Atheroma

  2015cites this paper
• Research Progress of Warfarin-associated Vascular Calcification and Its Possible Therapy

  2014cites this paper
• Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.

  2014cites this paper
• Novel ultrasound features for the identification of the vulnerable carotid plaque

  2014cites this paper
• Statins influence long term restenosis and cardiovascular events following carotid endarterectomy.

  2014cites this paper
• Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases

  2014cites this paper
• Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy

  2014cites this paper
• Viewofstatinsasantimicrobials incardiovascularrisk modification

  2014cites this paper
• View of statins as antimicrobials in cardiovascular risk modification.

  2014cites this paper
• Impact of risk scoring on decision‐making in symptomatic moderate carotid atherosclerosis

  2014cites this paper
• Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.

  2013cites this paper
• Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury – Rescue by High-Dose Statin Treatment

  2013cites this paper
• The role of osteoprotegerin in cardiovascular disease

  2013cites this paper
• Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque.

  2013cites this paper
• Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials

  2013cites this paper
• The prevention and regression of atherosclerotic plaques: emerging treatments

  2012cites this paper
• Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis

  2012cites this paper
• LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition

  2012cites this paper
• Lipid lowering efficacy of atorvastatin.

  2012cites this paper
• Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms.

  2012cites this paper
• Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update.

  2012cites this paper
• Novel biomarkers assessing the calcium deposition in coronary artery disease.

  2012cites this paper
• Identifying Asymptomatic Carotid Stenosis Patients at High Risk of Cerebrovascular Events

  2012cites this paper
• Statins and noncardiac vascular disease

  2012cites this paper
• Evaluation of cardiovascular disease markers in patients submitted to carotid artery stenting or endarterectomy

  2012cites this paper
• Estudio de las subfracciones lipoproteicas tras el tratamiento de simvastatina y ezetimiba, en monoterapia o combinado, en pacientes hiperlipidémicos

  2012cites this paper
• Carotid endarterectomy: still the standard of care for carotid bifurcation disease.

  2011cites this paper
• The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study

  2011cites this paper
• The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis.

  2011cites this paper
• [The role of statins in atherosclerotic peripheral arterial disease].

  2011cites this paper
• Effects of rosuvastatin on the coordinated proteomic response of human coronary smooth muscle cells to low density lipoproteins

  2011cites this paper
• Carotid plaque to predict the presence of coronary artery stenosis in a patient with extremely low LDL-C.

  2011cites this paper
• The role of statins in atherosclerotic peripheral arterial disease

  2011cites this paper
• Current Treatments for Carotid Artery Disease

  2011cites this paper
• Effect of Statin Therapy on Carotid Plaque Morphology

  2011cites this paper
• The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins?

  2010cites this paper
• Osteoprotegerin and cardiovascular disease

  2010cites this paper
• Asymptomatic carotid artery stenosis--medical therapy alone versus medical therapy plus carotid endarterectomy or stenting.

  2010cites this paper
• Pleiotropic effects of statins in atherosclerotic disease

  2010cites this paper
• Transatlantic debate. Asymptomatic carotid artery stenosis--medical therapy alone versus medical therapy plus carotid endarterectomy or stenting.

  2010cites this paper
• Statins have a dose-dependent effect on amputation and survival in peripheral artery disease patients

  year unknowncites this paper